Trump’s Drug Price Order Is More Bluster Than Substance

In this week’s edition of InnovationRx, we look at Trump’s drug pricing executive order, how the cofounder of Hims became a billionaire, the economic costs of cutting NIH spending, and more. To get it in your inbox, subscribe here.